Ossiam Has $1.25 Million Stake in HCA Healthcare, Inc. $HCA

Ossiam lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 29.6% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,270 shares of the company’s stock after selling 1,374 shares during the quarter. Ossiam’s holdings in HCA Healthcare were worth $1,253,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Saudi Central Bank acquired a new position in HCA Healthcare during the first quarter worth $26,000. WPG Advisers LLC bought a new position in shares of HCA Healthcare in the 1st quarter valued at approximately $27,000. Ameriflex Group Inc. acquired a new position in HCA Healthcare during the second quarter valued at approximately $27,000. Chung Wu Investment Group LLC acquired a new stake in shares of HCA Healthcare in the second quarter worth $27,000. Finally, Clearstead Trust LLC grew its stake in HCA Healthcare by 311.8% in the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after buying an additional 53 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on HCA. Barclays raised their price target on HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. The Goldman Sachs Group upped their price target on HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Stephens boosted their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock an “overweight” rating in a research report on Monday, October 27th. Raymond James Financial set a $525.00 price target on shares of HCA Healthcare in a report on Monday, October 27th. Finally, Zacks Research lowered shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 27th. Fourteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $469.50 on Thursday. The stock has a market cap of $107.14 billion, a price-to-earnings ratio of 18.15, a P/E/G ratio of 1.44 and a beta of 1.36. The firm has a fifty day moving average of $463.37 and a 200-day moving average of $412.38. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $520.00.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same quarter in the prior year, the business posted $4.90 earnings per share. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares in the company, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.